Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.77 USD | +3.39% |
|
+15.62% | +34.99% |
Jul. 15 | Piper Sandler Adjusts Core Laboratories Price Target to $17 From $18, Maintains Neutral Rating | MT |
Jul. 01 | Core Laboratories Inc.(NYSE:CLB) dropped from Russell Small Cap Comp Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.99% | 1.08B | |
+12.68% | 17.26B | |
0.00% | 8.78B | |
-21.69% | 2.61B | |
-23.62% | 2.4B | |
-23.43% | 1.9B | |
-18.96% | 930M | |
-0.21% | 728M | |
-32.02% | 633M | |
-37.60% | 563M |
- Stock Market
- Equities
- CLB Stock
- News Core Laboratories Inc.
- Core Laboratories N.V. announces an Equity Buyback for 10% of its issued share capital.